You are here Home Vaccines Vaccines Typhim Vi Details for Typhim Vi (typhoid) vaccine and its components. Listen Print Share Twitter Facebook Email Recently added This page was added on 04 June 2018. Updates made This page was updated on [date-counter-updated-date]. View history of updates Sponsor Sanofi-Aventis Australia Administration route Intramuscular injection Vaccine group Monovalent vaccines Description: Registered for use in people aged ≥2 years. Monovalent parenteral Vi polysaccharide typhoid vaccine Each 0.5 mL monodose pre-filled syringe contains: 0.025 mg purified Vi capsular polysaccharide of Salmonella typhi strain Ty2 <1.25 mg phenol For Product Information and Consumer Medicine Information about Typhim Vi visit the Therapeutic Goods Administration website. Additional vaccine information For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s. Related diseases Typhoid fever Page history Last updated 4 June 2018 Last reviewed 4 June 2018 Is there anything wrong with this page? Help us improve the Australian Immunisation Handbook What you were doing? (required) What went wrong? (required) Leave this field blank
